Docket No.: PT-1342-PCT OLEOSOME COMPOSITION WITH BIO-ACTIVES CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims the benefit of European Application No.22198376.0, filed September 28, 2022, which is incorporated by reference herein in its entirety. FIELD OF THE INVENTION [0002] The present invention relates to an oleosome composition comprising loaded isolated oleosomes being isolated oleosomes loaded with one or more sources of lipophilic dietary bioactive substances, which are present in the inside of said loaded isolated oleosomes. The present invention further relates to a product comprising the oleosome composition according to the present invention. The present invention also relates to a process for loading isolated oleosomes with one or more sources of lipophilic dietary bioactive substances to prepare an oleosome composition according to the present invention and to the use of the oleosome composition. BACKGROUND OF THE INVENTION [0003] Oleosomes, also known as "oil bodies", "lipid bodies", "lipid droplets" or "spherosomes", are pre-emulsified droplets or vesicles of oil stored in plant seeds and used as energy sources for plant growth and metabolism. Oleosomes are typically extracted from cells by a process of soaking, washing and grinding the seeds in the presence of water and subsequently filtering or decanting to remove solids and form an aqueous suspension. The suspension is centrifuged to separate the oleosomes, called isolated oleosomes. The size of the isolated oleosomes may further be enlarged. WO2021126408A1 by the present applicant provides a process for enlarging oleosomes. [0004] Lipophilic bioactive compounds such as lipids, vitamins, and phytochemicals serve important antioxidant, functional, nutritional, and structural roles in the human/animal body. A substantial number of these bioactive compounds are highly lipophilic such as polyunsaturated lipids. Docket No.: PT-1342-PCT [0005] Existing colloidal systems may be suitable matrices for the protection and delivery of these compounds. However, there is still a need for an improved matrix for glycerophospholipids providing improved oxidative stability and having improved stability in the gastric phase of the human digestive tract. There is a need for a carrier of specific lipophilic dietary bioactive substance to obtain a vehicle allowing to specifically regulate lipophilic dietary bioactive substances in higher amounts. There is a need for such carrier which can be incorporated in nutritional compositions. The present invention addresses this need. STATEMENT OF THE INVENTION [0006] The invention relates to an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance, which are present in the inside of the loaded isolated vegetable oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substance in the composition is present in the oleosomes. [0007] Furthermore, the invention relates to a product comprising the oleosome composition, wherein the product is selected from the group consisting of food products, feed products, pharmaceutical products, personal care products, nutritional compositions and industrial products. [0008] The present invention also relates to a process for preparing the oleosomes composition and the process comprises the steps of: a) blending one or more sources of one or more lipophilic dietary bioactive substance and optionally additional lipids with isolated vegetable oleosomes in a ratio of the source of lipophilic dietary bioactive substances to oleosomes of from 1:99 to 95:5; and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances and optionally additional lipids, which are present in the inside of the loaded isolated vegetable oleosomes, and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substances and at least 80 wt.% of the optionally additional lipids in the composition is present in the oleosomes. Docket No.: PT-1342-PCT [0009] Finally, the invention relates to a use of the oleosome composition as a carrier for one or more lipophilic dietary bioactive substance. More specifically, the invention relates to a use of the oleosome composition for the prevention of oxidation of lipophilic dietary bioactive substances. Moreover, the invention relates to a use of the oleosome composition for improving the stability of the lipophilic dietary bioactive substances in the gastric phase of the human digestive tract. [0010] Below several preferred features are disclosed. These features are applicable to the oleosome composition as well as to the product comprising the oleosome composition, the use of the oleosome composition and the process for loading isolated vegetable oleosomes with lipophilic dietary bioactive substances to prepare the oleosome composition. DETAILED DESCRIPTION [0011] The present invention is elucidated below with a detailed description. When used in this specification and claims, the terms "comprises" and "comprising" and variations thereof mean that the specified features, steps or integers are included. The terms are not to be interpreted to exclude the presence of other features, steps or components. Oleosome composition [0012] The invention relates to an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance and optionally lipids, which are present in the inside of the loaded isolated vegetable oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substance in the composition is present in the oleosomes. Preferably, at least 90 wt.% or at least 95 wt.% or at least 98 wt.% of the total weight of lipophilic dietary bioactive substance in the composition is present in the oleosomes. In fact, from 96 wt.% to 99.8 wt.%, from 97 wt.% to 99.0 wt.% of the total weight of lipids in the composition is present in the oleosomes. Isolated vegetable oleosomes Docket No.: PT-1342-PCT [0013] “Isolated vegetable oleosomes” as used in the present description, means oleosomes that have been isolated/removed from their natural source, i.e. vegetable source. The term encompasses oleosomes isolated from a single oleosome source, i.e. single strain or seed line of vegetable seeds. The term “isolated vegetable oleosomes” also encompasses blends of oleosomes that are isolated from more than one oleosome source, i.e. multiple strains and/or seed lines of vegetable seeds or combination of seeds of different vegetables sources. These isolated oleosomes may be present in the composition according to the invention and still be called “isolated”. [0014] Oleosomes are comprising intrinsic proteins such as mainly oleosin and minor amounts of caleosin and steroleosin. Without wishing to be bound by a particular theory, the present inventors observed that the oleosins contain a hydrophilic part, which is present at the isolated oleosomes’ surface, and a hydrophobic part which is anchored in the oil in the center of the oleosomes and ensures for oleosome stability. Even at alkaline conditions of pH 8 or higher, intrinsic proteins remain strongly bound, whereas weakly bound proteins will be removed in alkaline conditions. [0015] The isolated oleosomes may have a content of intrinsic proteins in an amount of from 0.2 to 10.0 wt.% based on the dry weight of the isolated oleosomes, such as from 0.3 to 8.0 wt.%, or from 0.3 to 6.0 wt.%. The applied method is described in the experimental section in paragraphs [0117]-[0120] of WO2021126408A1 which section is incorporated by reference. The isolated oleosomes may have a content of phospholipids in a range of from 0.2 to 6.0 wt.%, from 0.3 to 5.5 wt.%, from 0.4 to 5.0 wt.% based on the dry weight of the isolated oleosomes. The content of phospholipids may be determined using total phosphorus methods (AOCS Ca 19-86, AOCS Ca 12-55), TLC followed by GC, HPLC, or 31P-NMR. “Dry weight of the isolated oleosomes” as used in the present description means the weight of the dry (non-aqueous) part of the isolated oleosomes. The isolated oleosomes obtained by the extraction/isolation process are usually in the form of a creamy paste comprising a certain amount of water. [0016] The present invention differs from artificial oleosomes or artificial oil bodies (AOBs) in which a free oil e.g., fish oil is mixed with phospholipids and oleosin protein to form AOBs (= synthetic emulsions). The present invention comprises isolated natural oleosomes that are loaded with lipophilic dietary bioactive substance and optionally lipids Docket No.: PT-1342-PCT that are present in the inside of said loaded isolated sunflower oleosomes. The present composition is free of AOBs. Vegetable source [0017] The vegetable source for obtaining isolated vegetable oleosomes may be cells from pollens, spores, seeds or vegetative plant organs in which oleosomes or oleosomes-like organelles are present, preferably a plant seed. [0018] The vegetable source may be a member of the Brassicaceae, Amaranthaceae, Asparagaceae, Echium, Glycine, Astaraceae, Fabaceae, Malvaceae, Faboidae, Aracaceae, Euphorbiceae, Sinapsis, Lamiaceae, Cyperaceae, Anacardiaceae, Rosaceae, Betulaceae, Juglandaceae, Oleaceae, Lauraceae, Sapotaceae and/or Poaceae families. [0019] Preferably, the vegetable source is a plant seed from the group of plant species comprising: rapeseed (Brassica spp.), soybean (Glycine max), sunflower (Helianthus annuits) – and their corresponding mid or high oleic varieties- , cottonseed (Gossypium spp.), coconut (Cocus nucifera), linseed/flax (Linum usitatissimum) (including brown (also called bronze) and yellow (also called gold) linseed, hazelnut (Corylus avellana), maize and maize germ (Zea mays), almond (Prunus dulcis), cashew (Anacardium occidentale), olive (Olea), avocado (Persea americana), and shea (Butyrospermum parkii). Other examples that may be used are oil of palm (Elaeis guineeis), groundnut (Arachis hypogaea), castor (Ricinus communis), safflower (Carthamus tinctorius), mustard (Brassica spp. and Sinapis alba), coriander (Coriandrum sativum), squash (Cucurbita maxima), Brazil nut (Bertholletia excelsa), walnut (Juglands major), jojoba (Simmondsia chinensis), thale cress (Arabidopsis thaliana), wheat and wheat germ (Triticum spp.), amaranth (family of Amaranthus), sesame (Sesamum indicum), oat (Avena sativa), camelina (Camelina sativa), lupin (Lupinus), peanut (Arachis hypogaea), quinoa (Chenopodium quinoa), chia (Salvia hispanica), yucca, cocoa bean (Theobroma cacao), argan (Argania spinosa), and rice. For all of these, any variety with increased level of unsaturated fatty acids compared to the original seed variety may be used. Varieties may be obtained by natural selection or by genetic modification (GMO). [0020] Preferably, the isolated vegetable oleosomes are sourced from a vegetable source selected from the group consisting of rapeseed, soybean, cottonseed, coconut, brown linseed, yellow linseed, hazelnut, maize, sesame, almond, cashew, olive, avocado, shea, and Docket No.: PT-1342-PCT sunflower, and their corresponding mid or high oleic varieties, and any variety with increased level of unsaturated fatty acids compared to the original variety. [0021] The isolated vegetable oleosomes in the oleosome composition according to the present invention may be selected from the group consisting of isolated rapeseed oleosomes, isolated soybean oleosomes, isolated sunflower oleosomes, isolated linseed oleosomes, and a combination of two or more thereof. The isolated linseed oleosomes may be isolated yellow linseed oleosomes and/or isolated brown linseed oleosomes. The isolated sunflower oleosomes may be isolated mid-oleic (MO) sunflower oleosomes, isolated high- oleic (HO) sunflower oleosomes, high oleic-high stearic (HOHS) sunflower seeds, HP sunflower seeds (HP), high oleic-high palmitic (HOHP) sunflower seeds, or any combination of two or more thereof. [0022] More preferably, the isolated vegetable oleosomes are sourced from a vegetable source selected from the group consisting of rapeseed and rapeseed varieties with increased level of unsaturated fatty acids compared to the original rapeseed, sunflower, mid and high oleic sunflower, soybean, coconut, brown linseed, yellow linseed and hazelnut. Most preferably, the isolated vegetable oleosomes are sourced from a vegetable source selected from the group consisting of rapeseed, sunflower, mid and high oleic sunflower, soybean, brown linseed and yellow linseed. [0023] “Sunflower” as used in the present description means any type of sunflower seed belonging to the species Helianthus annuus. Several types of sunflower seeds exist, each characterized by the composition of the fatty acid profile of the oil present in these seeds. Regular sunflower seeds contain sunflower oil that is characterized by a typical composition of 45 to 74 wt.% linoleic acid (LA), 8 to 16 wt.% saturated acids, such as palmitic acid (PA) and stearic acid (SA), 14 to 43 wt.% oleic acid, and less than 1 wt.% of ALA, expressed on the total weight of fatty acid moiety of the oil. Other well-known varieties of sunflower seeds are so-called mid-oleic (MO) sunflower seeds, high-oleic (HO) sunflower seeds, high oleic-high stearic (HOHS) sunflower seeds, high-palmitic sunflower seeds (HP) and high oleic-high palmitic (HOHP) sunflower seeds, which can be obtained by natural selection or by genetic modification (GMO). Typically, high-oleic sunflower oil is characterized by a content of 2 to 17 wt.% LA, 6 to 13 wt.% saturated acids (PA and SA), 75 to 91 wt.% oleic acid, and less than 1 wt.% ALA, all expressed on the total weight of fatty acid moiety of the oil. Typically, mid-oleic sunflower oil is characterized by a content Docket No.: PT-1342-PCT of 18 to 45 wt.% LA, 7 to 12 wt.% saturated acids (PA and SA), 43 to 72 wt.% oleic acid, and less than 1 wt.% ALA, all expressed on the total weight of fatty acid moiety of the oil (see Codex alimentarius CXS 210-1999). [0024] “Rapeseed” as used in the present description means any type of rapeseed belonging to the species Brassica napus. Typically rapeseed oil (low erucic) has a fatty acid profile comprising palmitic acid (PA) (C16:0) in an amount of 4 wt.%, stearic acid (SA) (C18:0) in an amount of 2 wt.%, oleic acid (OA) (C18:1) in an amount of 56 wt.%, linoleic acid (LA) (C18:2) in an amount of 26 wt.%, and linolenic acid (ALA) (C18:3) in an amount of 10 wt.%, expressed on the total weight of fatty acid moiety of the oil (see Bailey’s Industrial Oil and Fat Products, 6th edition, 6th volume, 2005, Chapter 6 vegetable oils, Table 2). Rapeseed oil lends itself to genetic modification, and several rapeseed varieties giving oils with modified fatty acid profile have been developed. Typically rapeseed oil (low erucic) has a fatty acid profile of 51 to 30 wt.% linoleic acid (LA), 4 to 12 wt.% saturated acids, such as palmitic acid (PA) and stearic acid (SA), 51 to 70 wt.% oleic acid, and 5 to 14 wt.% of ALA, expressed on the total weight of fatty acid moiety of the oil (see Codex alimentarius CXS 210-1999). [0025] “Isolated rapeseed oleosomes” as used in the present description means oleosomes that have been isolated/removed from rapeseed. [0026] ”Soybean” as used in the present description means any type of soybean belonging to the species Glycine max. Raw soybeans contain approx. 18 wt.% of soybean oil that has a fatty acid profile comprising palmitic acid (C16:0) in an amount of 11 wt.% (range 7-14 wt.%), stearic acid (C18:0) in an amount of 4 wt.%, oleic acid (C18:1) in an amount of 22 wt.% (range 19-30 wt.%), linoleic acid (C18:2) in an amount of 55 wt.% (range 44-62 wt.%), and linolenic acid (ALA) (C18:3) in an amount of 8 wt.% (range 4-11 wt.%), expressed on the total weight of fatty acid moiety of the oil (see Bailey’s Industrial Oil and Fat Products, 6th edition, 6th volume, 2005, Chapter 6 vegetable oils, Table 2 and section 5.15). “Isolated soybean oleosomes” as used in the present description means oleosomes that have been isolated/removed from soybeans. [0027] “Linseed” as used in the present description means any type of linseed belonging to the species Linum usitatissimum. Linseed produces a vegetable oil that is highly unsaturated and that is known as linseed oil (flaxseed oil). Regular linseed oil (brown linseed) has a fatty acid profile comprising palmitic acid (C16:0) in an amount of 6 wt.%, Docket No.: PT-1342-PCT stearic acid (C18:0) in an amount of 3 wt.%, oleic acid (C18:1) in an amount of 17 wt.%, linoleic acid (C18:2) in an amount of 14 wt.%, and linolenic acid (C18:3) in an amount of 60 wt.%, expressed on the total weight of fatty acid moiety of the oil (see Bailey’s Industrial Oil and Fat Products, 6th edition, 6th volume, 2005, Chapter 6 vegetable oils, Table 2). There is a different type of engineered linseed (yellow) having a low level of linolenic acid (2%) and a high level of linoleic acid. [0028] Typically, linseed oil/flaxseed oil has a fatty acid profile of 8 to 30 wt.% linoleic acid (LA), 6 to 22 wt.% saturated acids, such as palmitic acid (PA) and stearic acid (SA), 10 to 36 wt.% oleic acid, and 44 to 70 wt.% of ALA, expressed on the total weight of fatty acid moiety of the oil (see Codex alimentarius CXS 210-1999). [0029] “Isolated linseed oleosomes” as used in the present description means oleosomes that have been isolated/removed from linseeds. [0030] The term “fatty acid profile” of a substance, such as an oil, a fat, isolated oleosomes, or an oleosome composition, as used in the present description, means the total of fatty acids that is present in the oily substance in the form of free fatty acids and in the form of the fatty acid moiety of a lipid (monoglyceride, diglyceride or triglyceride). For example, if an oil is comprising an amount of oleic acid expressed on total weight of the fatty acid profile, this amount is the total of oleic acid present in the oil as a free fatty acid and as oleic acid bound that is bound as the fatty acid moiety in the triglycerides, diglycerides and monoglycerides that are present in the oil. [0031] Isolated vegetable oleosomes can also be obtained from algal origin. In an aspect of the invention, oleosomes sourced from algae are excluded from and do not fall within the scope of the present invention. Lipophilic dietary bioactive substances [0032] The oleosome composition according to the present invention is comprising isolated vegetable oleosomes that are loaded with one or more sources of one or more lipophilic dietary bioactive substance. [0033] Lipophilic dietary bioactive substances are dietary bioactive substances that are oil-soluble (non-polar) in nature. Dietary bioactive substances or dietary bioactives are terms commonly used to describe food components which, although they are not essential, Docket No.: PT-1342-PCT may exert a positive effect on one or more physiological processes and hence may be beneficial to health. Their non-polar nature is often a limiting factor for their incorporation into commercial food products due to incompatibility with many food matrices. Furthermore, many hydrophobic bioactive components in foods are sensitive to food processing and storage and are poorly bioaccessible. [0034] The term “lipophilic dietary bioactive substances” as used in the current description encompasses the bioactive substance as such, as well as its form esterified to a fatty acid. Esterification may make dietary bioactive substances more fat-soluble (i.e.; lipophilic) so they may be easily loaded into the isolated oleosomes. [0035] Examples of oil-soluble vitamins are vitamin D, vitamin E, vitamin A, vitamin K, and ascorbyl palmitate (a derivative of vitamin C). Examples of phytosterols are plant sterols, such as β-sitosterol, campesterol, and stigmasterol, and plant stanols, such as sitostanol and campestanol. The lipophilic dietary bioactive substances according to the present invention do not include the lipids, ALA, LC-PUFA, and the additional lipids further specified. [0036] The one or more sources of one or more lipophilic dietary bioactive substance may be any suitable form for delivering the lipophilic dietary bioactive substance. It may be for example be an extract or a concentrated extract from a natural source such as a plant or a plant part. It may also be a synthetically prepared lipophilic dietary bioactive substance in a substantially pure form or suspended for example in oil. The isolated vegetable oleosomes may be loaded with one or more sources, each delivering a different lipophilic dietary bioactive substance. The isolated vegetable oleosomes may also be loaded with a source comprising more than one lipophilic dietary bioactive substance. [0037] In one aspect of the invention, the oleosome composition may comprise on or more sources of one or more lipophilic dietary bioactive substances that are selected from the group consisting of oil-soluble vitamins, phytosterols, curcuminoids, carotenoids, and flavonoids, and combinations of two or more thereof. More preferably, the oleosome composition may comprise on or more sources of one or more lipophilic dietary bioactive substances that are selected from the group consisting of oil-soluble vitamins, phytosterols, carotenoids, and flavonoids. Most preferably, the oleosome composition may comprise one or more source of one or more lipophilic dietary bioactive substance that is/are selected from the group consisting of oil-soluble vitamins and phytosterols. Docket No.: PT-1342-PCT [0038] The one or each of the lipophilic dietary bioactive substance is/are present in the oleosome composition in an amount of from 0.1 to 1000 microgram, from 0.2 to 800 microgram, or from 0.3 to 600 microgram per gram, based on the total weight of lipids of the oleosome composition. More specifically, the oleosome composition according to the invention is comprising lipophilic dietary bioactive substances in an amount of from 0.1 to 200 microgram per gram, such as 0.3 microgram per gram, 144 microgram per gram, based on the total weight of lipids of the oleosome composition, preferably from 50 to 900, from 100 to 800, from 200 to 700, or at least 500 microgram per gram of lipids. [0039] In a specific aspect, the oleosome composition according to the invention may comprise vitamin D as a lipophilic dietary bioactive substance in an amount of from 0.1 to 1000 microgram, from 0.2 to 800 microgram, or from 0.3 to 600 microgram per gram, based on the total weight of lipids of the oleosome composition. Depending on the use of the oleosome composition, vitamin D may be present in an amount that is at the lower end of the range, e.g., for a nutritional composition given the EU regulation recommending a daily intake for infants of 10 micrograms per day and adults 15 micrograms per day. Vitamin D may also be present in an amount of the upper end of the range above, e.g., when used as “fortification” or supplements. [0040] In a specific aspect, the oleosome composition according to the invention may comprise vitamin E as a lipophilic dietary bioactive substance in an amount of from 0.1 to 1000 microgram, from 100 to 800 microgram, or from 300 to 600 microgram per gram, based on the total weight of lipids of the oleosome composition. Loaded isolated vegetable oleosomes [0041] “Loaded isolated (vegetable) oleosomes,” “isolated (vegetable) oleosomes loaded with …” as used in the present description means that additional components, such as lipophilic dietary bioactive substances, are encapsulated by the (vegetable) oleosomes, thus present in the inside thereof. [0042] As stated, it is preferred that a large amount (at least 80 wt.%, at least 90%, or at least 95%), substantially all, or all of the lipophilic dietary bioactive substances is present in loaded isolated vegetable oleosomes. The remaining amount of lipophilic dietary bioactive substances, i.e. the amount of lipophilic dietary bioactive substances that is not present in the loaded isolated vegetable oleosomes expressed on the total amount of Docket No.: PT-1342-PCT lipophilic dietary bioactive substances that are present in the oleosome composition, may be present in the composition in free form, e.g., outside of the oleosomes; the composition then comprises free lipophilic dietary bioactive substances in addition to loaded isolated oleosomes. In an aspect, substantially all lipophilic dietary bioactive substances are present inside oleosomes for optimal protection of these lipophilic dietary bioactive substances. The combination of lipophilic dietary bioactive substances that are present in the oleosomes and the free lipids thus adds up to 100 wt.% based on the total weight of lipids in the oleosome composition. Additional lipids [0043] In addition to loading the isolated vegetable oleosomes with one or more sources of one or more lipophilic dietary bioactive substances to obtain loaded isolated vegetable oleosomes comprising lipophilic dietary bioactive substances, one or more lipids may be loaded into the isolated vegetable oleosomes. [0044] Per definition, oleosomes comprise lipids being phospholipids (and optionally diacylglycerides (DAGs), monoacylglycerides (MAGs), free fatty acids (FFAs), and one or more combinations thereof) at the interphase as well as triglycerides (TAGs) in the center of the oleosomes. Oleosomes are present as vesicles of oil storage in their natural source. Once isolated/removed from their natural source, they are known as isolated oleosomes. By loading of oleosomes, additional lipids may be added into the oleosome composition according to the present invention. Moreover, lipids that may be present in the composition and that are not inside the oleosomes (so-called “free lipids”), are limited. [0045] The amount of free lipids in the oleosome composition can be quantified by extracting the free lipids from the oleosome composition with heptane. The heptane will only extract the free lipids, not the lipids inside the oleosomes. Subsequently the amount of lipids in the heptane phase is quantified. Quantification can be done by means of GPC analysis. [0046] The amount of lipids in the oleosome composition that is present in the oleosomes is calculated as the difference between the total amount of lipids (for example measured by Soxhlet method) and the amount of free lipids in the oleosome composition. [0047] “Total weight of lipids” as used in the present description means the weight of all the lipids present in the composition, thus both present in the oleosomes (in the center Docket No.: PT-1342-PCT as well as in the interphase layer) and outside of the oleosomes, being the free lipids. Preferably, substantially all the lipids are present in the oleosomes. In the current invention, the term “lipid” or “lipids” is encompassing free fatty acids, mono-, di-, tri-glycerides, and phospholipids. [0048] The total amount of lipids in the oleosome composition may be up to 99.6 wt.% based on the total dry weight of the oleosome composition. For example, the total amount of lipids in the oleosome composition may be between 80.0 and 99.7 wt.%, from 85.0 to 99.0 wt.%, or from 90.0 to 99.0 wt.% based on the total dry weight of the oleosome composition. The majority of the remaining part of the dry matter of the oleosome composition are the proteins. . [0049] Examples of one or more lipids or one or more sources of fatty acids that may be loaded into the isolated vegetable oleosomes are, but are not limited to, triglycerides having saturated C16 fatty acids that are positioned at the sn2 position, LC-PUFA, MCFA, ALA, LA, or combinations of two or more thereof. In one aspect, the oleosomes are further loaded with one or more sources selected from the group consisting of triglycerides having saturated C16 fatty acids that are positioned at the sn2 position, alpha linolenic acid (ALA), long chain poly-unsaturated fatty acids (LC-PUFA), medium chain fatty acids (MCFA), and combinations of two or more thereof. [0050] “LC-PUFA” as used in the present description means long-chain poly- unsaturated fatty acids. These poly-unsaturated fatty acids have a chain (“backbone”) comprising 20 or more carbon atoms and comprise more than one double bond in their backbone. [0051] Examples of specific LC-PUFA fatty acids are the following: ^ ARA (or AA) or arachidonic acid, which is an omega-6 fatty acid, and its shorthand name is 20:4(ω-6) or 20:4(n-6) or 20:4n6 ^ DHA or docosahexaenoic acid, which is an omega-3 fatty acid, and its shorthand name is 22:6(ω-3) or 22:6(n-3) or 22:6n3 ^ EPA or eicosapentaenoic acid or icosapentaenoic acid, which is an omega-3 fatty acid, and its shorthand name is 20:5(ω-3) or 20:5(n-3) or 20:5n3 ^ DPA or docosapentaenoic acid, which is an omega-3 fatty acid, and its shorthand name is 22:5(ω-3) or 22:5(n-3). Docket No.: PT-1342-PCT [0052] The LC-PUFA may be selected from the group consisting of arachidonic acid (ARA), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and combinations of two or more thereof. [0053] As one or more sources of LC-PUFA one or more sources of DHA and/or one or more sources of ARA may be used. As one or more sources of DHA, Schizochytrium (a unicellular coastal marine eukaryote) oil may be used. As one or more sources of ARA, Mortierella alpina (a soil fungus) oil may be used. In an example, Schizochytrium oil has a fatty acid composition comprising between 37 and 50 wt.%, preferably between 44 and 48 wt.%, for example 46 wt.%, of DHA (being C22:6n3). In an example, Mortierella alpina oil has a fatty acid composition comprising between 40 and 50 wt.%, preferably between 44 and 48 wt.%, for example 46 wt.%, ARA (being C20:4n6). [0054] “MCFA” or “medium-chain fatty acids” as used in the present description means saturated fatty acids with a carbon chain length of 6, 8, 10, or 12 carbon atoms. MCFA are naturally found in a variety of lipid sources including coconut oil, palm kernel oil, dairy lipids, or fractions thereof, such as C6 and C8 rich fractions of coconut oil. [0055] “ALA” as used in the present description means alpha-linolenic acid or α- linolenic acid, which is an omega-3 fatty acid, and its shorthand name is 18:3(ω-3) or 18:3(n- 3). In the present description, ALA is referring only to C18:3 ccc wherein ccc stands for three cis double bonds. As one or more sources of ALA, flaxseed oil may be used. In an example, flaxseed oil is comprising ALA in an amount of from 55 to 60 wt.%, preferably from 57 to 59 wt.%, such as 58 wt.% based on total weight of the fatty acid profile of the oil. [0056] “LA” as used in the present description means linoleic acid, which is an omega-6 fatty acid, and its shorthand name is 18:2(ω-6) or 18:2(n-6). [0057] “Triglyceride having saturated C16 fatty acids that are positioned at the sn2 position” as used in the present description means a triglyceride having at the 2-position of its glycerol backbone (sn2 position) a saturated C16 fatty acid. An example thereof is 1,3- dioleoyl-2-palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), and 1- oleoyl-2-palmitoyl-3-linoleoyl glyceride (OPL), wherein the palmitic acid (saturated C16) is present at the 2-position. “O” stands for oleic acid, “P” for palmitic acid, and “L” for linoleic acid. OPO is known to be an important component of human breast milk. These triglycerides may have a triglyceride composition comprising from 30 to 50 wt.% of Docket No.: PT-1342-PCT saturated fatty acid residues having 16 carbon atoms and from 30 to 70 wt.% of unsaturated fatty acid residues having 18 carbon atoms, wherein 50 to 80 wt.%, such as from 52 to 75 wt.% of the saturated fatty acid residues having 16 carbon atoms are present at the 2-position in a triglyceride. [0058] In the oleosome composition, the fatty acid profile of the lipids may have a ratio of omega-6 fatty acids over omega-3 fatty acids (n-6/n-3 or ω-6/ω-3 or n-6:n-3 or ω- 6:ω-3) in a range of from 0.2:1 to 7.0:1, more preferably from 0.2:1 to 5.0:1, more preferably from 0.2:1 to 3.0:1, more preferably from 0.2:1 to 1.0:1 Additional ingredients [0059] Other ingredients may be added to the composition, e.g., to stabilize the oleosomes in the composition. Examples thereof are proteins or thickeners, the latter leading to an increase in viscosity which in turn may lead to more stable compositions. Loaded isolated vegetable oleosome size and form [0060] The average globule diameter of the loaded isolated vegetable oleosomes is expressed as the D50-value. The D50-value of oleosomes is the diameter below which 50% of the volume of oleosome particles lies, and it is expressed in micron (= micrometer, symbol: µm). To measure the average globule diameter (D50-value) of the oleosomes, the oleosomes are considered spherical and in the case of non-spherical oleosomes, the diameter is considered as being the largest dimension that can be measured between two opposite points on the surface thereof. [0061] To be able to measure the globule diameter of the oleosomes, a Mastersizer 3000 from Malvern equipped with a Hydro module was used during the measurements. A refractive index of 1.47 is used to measure the oleosomes size. The concentration of the oleosomes in the buffer is such that an obscuration in the range from 8.0 to 8.5% in the Mastersizer equipment will be obtained. Obscuration within the Mastersizer is the amount of light blocked or scattered, by the particles. Therefore, the oleosomes are diluted in a buffer solution containing 10 mM sodium phosphate, pH 7.4, and 1.0 wt.% sodium dodecyl sulfate (SDS). For example, about 0.2 wt.% of oleosomes is diluted in the buffer solution and the dilution is further adjusted to obtain the obscuration. Once this optimal obscuration is Docket No.: PT-1342-PCT obtained, the globule diameter is measured, and the average globule diameter (D50-value) can be calculated. [0062] The loaded isolated oleosomes in the oleosome composition may have an average globule diameter of the oleosomes in a range of from 0.3 to 15 microns, preferably from 0.6 to 8.0 microns, more preferably from 1.0 to 5.5 microns. [0063] Typically, loaded isolated oleosomes have an average globule diameter of about 80.3 to 2.5 microns, from 1.00.6 to 2.2 microns, or from 1.20 to 2.0 microns. [0064] Preferably, the loaded isolated oleosomes in the oleosome composition have an average globule diameter in a range of from more than 2.5 to 15 microns, preferably from 3.0 to 12 microns, more preferably from 4.0 to 10 microns. Such a size is important when being used for infant formula since the average globule size of human breast milk is about 5 microns. For obtaining the loaded isolated oleosomes having an average globule diameter in a range of from 4 to 15 microns an additional process step of enlarging the isolated oleosomes prior to, subsequently to or simultaneously to loading, may be required. [0065] The oleosome composition of the present invention may be in paste form or powder form. The powder form may be obtained after the isolated oleosomes have been loaded, e.g., by spray drying, fluid bed drying, freeze-drying, or vacuum drying. A carrier such as for example maltodextrin may be added to the composition prior to spray-drying. [0066] The obtained powder may be used as a supplement. Product comprising the oleosome composition [0067] The invention also relates to products comprising the oleosome composition of the present invention, wherein the product is selected from the group consisting of food products, feed products, pharmaceutical products, personal care products, nutritional compositions, and industrial products. [0068] The product according to the second aspect of the invention may be a nutritional composition comprising the oleosome composition in a range of from 0.1 to 70.0 wt.%, preferably between 2.0 and 50.0 wt.% on dry matter of the nutritional composition. For example, in an amount of from 5.0 to 65.0 wt.%, from 9.3 to 60.0 wt.%, or from 20.6 to 55.0 wt.% on dry matter of the nutritional composition. More specifically in an amount of from 0.2 to 22 wt.%, such as 6.7 wt.%. The nutritional composition is further comprising at least one additional nutritional ingredient, other than oleosomes. The at least one nutritional Docket No.: PT-1342-PCT ingredient is not derived from oleosomes. Nutritional ingredients are ingredients that contribute to the caloric intake and/or provide micronutrients. With “on dry matter of the nutritional composition” is meant that it is expressed on all components except water. [0069] The additional nutritional ingredient may be selected from the group consisting of sources of proteins, sources of fats, sources of carbohydrates, sources of micronutrients, and combinations of two or more thereof. These sources do not comprise oleosomes. Preferably, these sources do not comprise isolated vegetable oleosomes, isolated oleosomes from any other origin, loaded isolated oleosomes from any other origin or a combination of two or more thereof. [0070] The term “micronutrients” is encompassing nutrients that an organism needs in small quantities for the proper functioning of its metabolism. Examples of micronutrients are, but are not limited to vitamins, minerals, trace elements, essential amino acids and essential fatty acids, [0071] The additional nutritional ingredient may, more preferably, be selected from the group consisting of proteins, carbohydrates, fats, minerals, trace elements, essential amino acids, essential fatty acids, vitamins, and a combination of two or more thereof. [0072] When sources of fats (lipids) are added to the product according to the invention, these fats are free fats that are added after the preparation of the loaded isolated oleosomes. These are hence not present inside the loaded isolated oleosomes. The fatty acid profile (or fatty acid composition FAC) of the oleosome composition will hence not necessarily be the FAC of the final product. [0073] The nutritional composition may further comprises one or more non- nutritional ingredient. Non-nutritional ingredients according to the invention are ingredients that do not substantially add to the caloric intake and/or do not substantially provide micronutrients. Examples of non-nutritional ingredients are flavors, colorants, emulsifiers, acid regulators such as citric acid or lactic acid, preservatives, and the like. The non- nutritional ingredients may be from a natural or synthetic origin. [0074] In the nutritional composition the combination of the oleosome composition, the at least one additional nutritional ingredient and optionally water and/or non-nutritional ingredients make up 100 wt.%. [0075] Examples of nutritional compositions according to the present invention may be compositions that are developed to cover the nutritional needs, either as a supplement or Docket No.: PT-1342-PCT as complete nutrition. The people that are targeted for the nutritional composition according to the invention relate to specific groups of people, such as, but not limited to, preterm infants, infants, toddlers, elderly people, pregnant women, athletes, or humans having nutritional deficiencies and/or having a deficient immune system. In a specific aspect, the nutritional composition is an infant formula. This infant formula may be milk-based, e.g. with milk protein isolate and/or caseinate and/or whey protein, or it may be plant-based, e.g. with almond, soy, rice, corn and/or pea proteins. In a specific aspect, the nutritional composition is for pregnant women. The nutritional compositions may be designed for people suffering from a more specific disease state such as cancer, chronic obstructive pulmonary disease, and later-stage kidney disease, and others. Amongst others, nutritional compositions may be helpful for people who struggle with a loss of appetite, have difficulty with chewing, have trouble preparing balanced meals, and/or are recovering from surgery or an illness. If the nutritional composition is meant for complete nutrition, it can provide a healthy balance of protein, carbohydrate, and/or fat. [0076] These nutritional compositions can be in the form of liquid, as a ready-to- drink formula, or used in feeding tubes. It can also be in the form of a formula base i.e., a powder or a concentrated liquid, to be dissolved in water or another fluid for the preparation of a ready-to-drink nutritional composition. The nutritional composition may also be in the form of a pudding or a jelly, or the form of a cookie or a snack bar, or any other form. [0077] In yet another aspect of the invention, the at least one nutritional ingredient other than oleosomes is not an emulsifier. [0078] In one specific aspect, the nutritional composition according to the invention comprising the oleosome composition is a food product, such as infant formula, preferably growing-up milk. The infant food product or infant formula is a term well-known in the art and it refers to food that is specifically manufactured for infants and it may be characterized in that it is soft, and easily consumable by infants and has a nutritional composition adapted to the specific needs at each growth stage. [0079] The infant food product according to the invention may be in the form of a liquid, such as a ready-to-drink infant food product. It can also be in the form of a formula base, i.e., a powder or a concentrated liquid, to be dissolved in water or another fluid for the preparation of a ready-to-drink infant food product. The infant food product may also be in the form of a pudding or a jelly, or in the form of a cookie or a snack bar, or in any other Docket No.: PT-1342-PCT form. The infant food product of the present invention is encompassing the three forms available on the market, i.e., powder (infant base powder), liquid concentrate, and ready-to- feed liquids. [0080] It may be a first age infant formula, for infants from birth to age of 6 months, a follow-on formula (also called second age infant formula), for infants from an age of 6 to 12 months, or a growing-up formula (also called third age infant formula) for infants from the age 1 to 3 years. [0081] In another specific aspect, the nutritional composition according to the invention comprising the oleosome composition is a nutritional composition, such as a nutritional drink, a nutritional powder, such as a sport nutrition powder; a powder for food fortification, a nutritional bar or cookie, such as a sports nutrition bar; or a nutritional supplement. [0082] In a specific aspect, the nutritional composition is an infant formula, and the infant formula - has a total content of lipids in a range of from 2.5 to 4.5 wt.%, from 2.8 to 4.0 wt.%, or from 3.0 to 3.4 wt.% on total weight of the infant formula, - wherein at least 90%, at least 95%, or even substantially all of the lipids of the infant formula is present in the oleosome composition, and wherein the oleosome composition: - is comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more source of one or more lipophilic dietary bioactive substances; which are present in the inside of the loaded isolated oleosomes and - is comprising an amount of one or more lipophilic dietary bioactive substance in a range of from 0.1 to 400 microgram, from 0.2 to 300 microgram, or from 0.3 to 200 microgram per gram, based on the total weight of lipids of the oleosome composition; - wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substance in the composition is present in the oleosomes; - and wherein at least 80 wt.% of the total weight of lipids in the oleosome composition is present in the oleosomes. [0083] Examples of other types of food and feed products include but are not limited to drinks such as coffee, black tea, powdered green tea, cocoa, and juice; milk component- containing drinks, such as raw milk, processed milk, and lactic acid drinks; a variety of Docket No.: PT-1342-PCT drinks including nutrition-enriched drinks, such as calcium-fortified drinks and the like and dietary fiber-containing drinks; dairy products, such as butter, cheese, vegan cheese, yoghurt, coffee whitener, whipping cream, custard cream, and custard pudding; iced products such as ice cream, soft cream, lacto-ice, ice milk, sherbet, and frozen yogurt; processed fat food products, such as mayonnaise, margarine, spread, and shortening; soups; stews; seasonings such as sauce and dressings; a variety of paste condiments represented by kneaded mustard; a variety of fillings typified by jam and flour paste; a variety or gel or paste-like food products including red bean-jam, jelly, and foods for swallowing impaired people; food products containing cereals as the main component, such as bread, noodles, pasta, pizza pie, and corn flake; Japanese, US and European cakes, candy, cookie, biscuit, hot cake, chocolate, and rice cake; kneaded marine products represented by (boiled) fish cake; live-stock products represented by ham, sausage, hamburger and steak; daily dishes such as cream croquette, paste for Chinese foods, gratin, and dumpling; foods of delicate flavor, such as salted fish guts and a vegetable pickled in sake lee; liquid diets such as tube feeding liquid food; supplements; and pet foods. Whereas traditional processes for preparing food and feed products will require an emulsification or homogenization step, the process of the current invention for preparing the food and feed products does not need such a homogenization or emulsification step. A simple blending of the oleosome composition with the other ingredients is sufficient. [0084] Examples of such pharmaceutical products include products comprising therapeutic agents, diagnostic agents, and delivery agents. As a therapeutic or diagnostic agent, the product will additionally contain an active ingredient. The active ingredient can be anything that one wishes to deliver to a host. The active ingredient may be a protein or peptide that has therapeutic or diagnostic value. Such peptides include antigens (for vaccine formulations), antibodies, cytokines, blood-clotting factors, and growth hormones. An example of a pharmaceutical product is a parenteral emulsion containing the oleosome composition and a drug. [0085] Examples of such personal care products include soaps, cosmetics, skin creams, facial creams, toothpaste, lipstick, perfumes, make-up, foundation, blusher, mascara, eyeshadow, sunscreen lotions, hair conditioner, and hair coloring. Docket No.: PT-1342-PCT [0086] Examples of such industrial products include paints, coatings, lubricants, films, gels, drilling fluids, paper sizing, latex, building, and road construction material, inks, dyes, waxes, polishes, and agrochemical formulations. [0087] Furthermore, the current invention relates to a process for preparing the product according to the invention comprising the oleosome composition; the process comprising the step of blending the oleosome composition with the at least one other ingredient other than oleosomes. The process preferably does not comprise a further step of emulsification of the oleosome composition with the at least one other nutritional composition. Process for loading [0088] The present invention also relates to a process for preparing the oleosomes composition and the process comprises the steps of: a) blending one or more sources of one or more lipophilic dietary bioactive substance and optionally additional lipids with isolated vegetable oleosomes in a ratio of the source of lipophilic dietary bioactive substances to oleosomes of from 1:99 to 95:5; and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances and optionally additional lipids, which are present in the inside of the loaded oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substances and at least 80 wt.% of the optionally additional lipids in the composition is present in the oleosomes. [0089] In one aspect of the invention, the process for preparing the oleosomes composition comprises the steps of: a) blending one or more sources of one or more lipophilic dietary bioactive substance with isolated vegetable oleosomes in a ratio of the source of lipophilic dietary bioactive substances to oleosomes of from 1:99 to 95:5; and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances, which are present in the inside of the loaded oleosomes and Docket No.: PT-1342-PCT wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substances in the composition is present in the oleosomes. [0090] In another aspect of the invention, the process for preparing the oleosomes composition comprises the steps of: a) blending one or more sources of one or more lipophilic dietary bioactive substance and additional lipids with isolated vegetable oleosomes in a ratio of the source of lipophilic dietary bioactive substances to oleosomes of from 1:99 to 95:5; and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances and additional lipids, which are present in the inside of the loaded oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substances and at least 80 wt.% of the additional lipids in the composition is present in the oleosomes. [0091] The isolated vegetable oleosomes may comprise lipophilic dietary bioactive substances that are by nature present in vegetable seeds. These isolated vegetable oleosomes are loaded – according to the process of the invention - with one or more lipophilic dietary bioactive substance to obtain an oleosome composition comprising loaded isolated vegetable oleosomes. The loading (= blending and subjecting to high-shear force) with specific lipophilic dietary bioactive substance allows obtaining oleosomes comprising lipophilic dietary bioactive substances in higher amount than are by nature present in the oleosome and/or lipophilic dietary bioactive substances that are by nature not present in the oleosome. The additional lipophilic dietary bioactive substances added are (mostly) present inside the loaded isolated vegetable oleosomes. In other words, at least 80 wt.% of the total weight of lipophilic dietary bioactive substances in the oleosome composition that is obtained from the process, is present in the loaded isolated vegetable oleosomes. Preferably, at least 90 wt.% or at least 95 wt.% or at least 98 wt.% of the total weight of lipophilic dietary bioactive substance in the oleosome composition is present in the loaded isolated vegetable oleosomes. [0092] More details regarding the several steps of the process are disclosed below. Step a) Docket No.: PT-1342-PCT [0093] The process starts with isolated vegetable oleosomes or enlarged isolated vegetable oleosomes and blending these with one or more source of one or more lipophilic dietary bioactive substance. The ratio between the source and the oleosomes , preferably the ratio between the source of one or more lipophilic dietary bioactive substance to the lipids of the oleosomes (=the lipids already present in the oleosomes) is from 1:99 to 95:5, preferably from 5:95 to 80:20, more preferably from 10:90 to 60:40. Optionally, additional lipids may also be blended with the isolated sunflower oleosomes for the purpose of being loaded into the isolated oleosomes. When also additional lipids are blended with the isolated vegetable oleosomes, the ratio between the one or more source of one or more lipophilic dietary bioactive substance and additional lipids to oleosomes is from 1:99 to 95:5, preferably from 5:95 to 80:20, more preferably from 10:90 to 60:40. [0094] Methods for obtaining isolated oleosomes are well known in the art. Typically, vegetable seeds are obtained using agricultural cultivation practices well known to a person skilled in the art. The seeds are harvested and, if desired, materials such as stones or seed hulls (de-hulling) may be removed from the seeds by, for example, sieving or rinsing. Subsequently the seeds are processed by mechanical pressing, grinding or crushing. A liquid phase, e.g. water, may also be added prior to grinding of the seeds, which is known as wet milling. Following grinding, a slurry is obtained and filtrated. The filtrate may be subsequently separated into two liquid phases, a watery phase and an oily oleosome containing phase, i.e. the isolated vegetable oleosomes, by means of any suitable separation technique such as, but not limited to centrifugal acceleration. Alternatively, the slurry obtained after grinding may be submitted to a liquid-solid separation (two-phase separation) or a liquid-solid-liquid separation (three-phase separation) using a centrifugal decanter. Both separation techniques follow the same operating principle. [0095] The isolated vegetable oleosomes or enlarged isolated vegetable oleosomes in step a) may have a dry matter content in a range of from 30 to 80 wt.% on the total weight of the oleosomes, the remainder up to 100 wt.% being an aqueous solution such as but not limited to water. The isolated oleosomes that are subjected to step a) may have a pH in a range of from 3.5 to 10.0, preferably from 4.5 to 8.5, more preferably from 5.5 to 7.5. [0096] The isolated sunflower oleosomes used in step a) of the process of the present invention may be washed or non-washed isolated sunflower oleosomes. Docket No.: PT-1342-PCT [0097] Briefly stated, enlarged isolated vegetable oleosomes may be obtained by carrying out a process of applying high-shear centrifugation force to the isolated oleosomes and/or a process of applying high-shear mixing to the isolated oleosomes, such as described in WO2021126408A1 by the present applicant. [0098] Isolated vegetable oleosomes or enlarged isolated vegetable oleosomes that are subjected to step a) of the process according to the invention, may be in liquid form or in dehydrated form. When these vegetable oleosomes are in dehydrated form, they are prior to step a) suspended in an aqueous solution, such as but not limited to water, in order to have a dry matter content in a range of from 30 to 80 wt.% on the total weight of the oleosomes. Step b) [0099] The blend obtained from step a) is subjected to a high-shear force to obtain an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance and optionally additional lipids, which are present in the inside of said loaded isolated vegetable oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substances and at least 80 wt.% of the optionally additional lipids in the composition is present in the oleosomes. [0100] The high-shear force to which the blend obtained in step a) is subjected, may be a high-shear mixing, a high-pressure homogenization, an (ultra)sonication, or a hydrodynamic cavitation mixing. The high shear mixing in step b) may be applied for a period of time in a range of from 0.5 to 10 minutes, preferably 1 to 8 minutes, more preferably 2 to 6 minutes. The high-pressure homogenization may be carried out with a pressure up to 300 bar, resulting in a smooth and stable composition. In case the high-shear force in step b) is obtained using high-shear mixing, the high-shear mixing may be applied using a rotor-stator high-shear mixer at a tip velocity in a range of from 1.6 to 12.8 m/s, preferably 1.9 to 11.2 m/s, more preferably 2.6 to 9.6 m/s. [0101] It is surprisingly found that high shear is applicable to obtain the loaded isolated oleosomes in the oleosome composition of the present invention. The oleosomes are still intact and the loaded material is present in the inside of the oleosomes. [0102] In one aspect of the invention, the process for preparing the oleosomes composition comprises the steps of: Docket No.: PT-1342-PCT a) blending one or more sources of one or more lipophilic dietary bioactive substance and optionally additional lipids with isolated vegetable oleosomes in a ratio of the source of lipophilic dietary bioactive substances to oleosomes of from 1:99 to 95:5; and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances and optionally additional lipids, which are present in the inside of the loaded isolated vegetable oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substances and at least 80 wt.% of the optionally additional lipids in the composition is present in the oleosomes, wherein the high-shear mixing is applied ^ for a period of time in a range of from 0.5 to 10 minutes, preferably 1 to 8 minutes, more preferably 2 to 6 minutes, and ^ using a rotor-stator high-shear mixer at a tip velocity in a range of from 1.6 to 12.8 m/s, preferably 1.9 to 11.2 m/s, more preferably 2.6 to 9.6 m/s [0103] Amongst others it has been found that the process for preparing the oleosomes of the present invention is more convenient, and/or more simple than the process for preparing the synthetic emulsion. The process allows to get a homogeneous product, without or with a very limited amount free lipids present, whereas the amount of free lipids is significant for the synthetic emulsions. Additional steps Washing step [0104] A washing step may be included between step a) and b). The product obtained in step a) may be washed by re-suspending it in a floatation solution of lower density (e.g. water, aqueous buffer with neutral to alkaline pH up to 9.5) and by subsequently separating it again from the aqueous phases by means of any suitable separation technique such as, but not limited to centrifugation. The washing procedure may be repeated several times, from one up to three times. Docket No.: PT-1342-PCT Heat-treatment step [0105] The isolated vegetable oleosomes or enlarged sunflower oleosomes may be heat-treated prior to step a) or after step b) of the process of the invention. Furthermore, the oleosome composition obtained in step b) may be subjected to a heat treatment step. [0106] The heat treatment may be a pasteurization treatment or an ultra-high- temperature (UHT) treatment. Pasteurization treatment involves heating the oleosome composition at 65°C to 70°C for 30 minutes in batch, or 80°C to 86°C for 15 to 30 seconds in a continuous-flow process (High-temperature short time Pasteurization (HTST Pasteurization)). UHT treatment involves heating of the oleosome composition at a temperature of 135°C to 150°C in a continuous-flow process and holding at that temperature for one or more seconds, up to 5 seconds, before cooling rapidly to room temperature. The heat treatment step of the oleosome composition is applied to further avoid microbial contamination of the oleosomes. Dehydration step [0107] The oleosome composition obtained in step b) may be subjected to a dehydration step. Dehydration steps well known to the person skilled in the art are amongst others spray drying, fluid bed drying, freeze-drying, and vacuum drying. The thus obtained oleosomes are in a more concentrated liquid form or a powder form. In one aspect of the invention, the dehydration step is a spray-drying step. Enlargement step [0108] The isolated vegetable oleosomes may be subjected to a step of enlarging the oleosomes prior to step a) of the process according to the invention. Furthermore, the product obtained prior to step b) may be subjected to a step of enlarging the oleosomes to form enlarged oleosomes. This may be carried out by a process of applying high-shear centrifugation force to the isolated oleosomes and/or a process of applying high-shear mixing to the isolated oleosomes, such as described in WO2021126408A1 by the present applicant. [0109] Alternatively, the step of enlarging and loading the isolated vegetable oleosomes can be done simultaneously. For simultaneously loading and enlarging isolated vegetable oleosomes, the high-shear force in step b) may be obtained by using high-shear Docket No.: PT-1342-PCT mixing that is applied for a period of time in a range of 3.0 to 10.0 minutes, preferably 3.5 to 8.0 minutes, more preferably 4.0 to 6.0 minutes. [0110] Preferably, for simultaneously loading and enlarging isolated vegetable oleosomes, the high-shear force in step b) is applied to isolated vegetable oleosomes that have been washed prior to step a). Use of an oleosome composition [0111] Finally, the invention relates to the use of the oleosome composition as a carrier for one or more lipophilic dietary bioactive substance. [0112] More specifically, the oleosome composition can be used for the prevention of oxidation of lipophilic dietary bioactive substances that is loaded into isolated vegetable oleosomes and/or improving the stability of the one or more lipophilic dietary bioactive substance in the gastric phase of the human digestive tract. [0113] The current invention relates to the use of the oleosome composition as a carrier providing oxidative stability while allowing the tailoring of the fatty acid profile according to the desired need. [0114] The current invention relates to the use of the oleosome composition as a carrier of specific lipophilic dietary bioactive substance to obtain a vehicle allowing to specifically regulate lipophilic dietary bioactive substances in higher amounts. Effects of the invention [0115] The present invention provides a composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance which are present in the inside of the loaded oleosomes. The oleosome composition of the present invention provides a matrix that offers improved protection of one or more lipophilic dietary bioactive substance against oxidation and/or improved stability in the gastric phase of the human digestive tract. Additionally, nutritional compositions wherein at least 90%, or even substantially all of the lipids are present in the oleosome composition, will be stable without the need of any emulsifier. Docket No.: PT-1342-PCT [0116] The one or more lipophilic dietary bioactive substance can still be active and may provide a synergistic effect while loaded onto the carrier in comparison with artificial blends. [0117] The simpler process resulted further in a more stable product having a longer shelf life and/or having less free lipids in the oleosome composition than in the synthetic emulsions. CLAUSES 1. An oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance, which are present in the inside of said loaded vegetable oleosomes. 2. An oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance, which are present in the inside of said loaded vegetable oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substance in the composition is present in the oleosomes. 3. The oleosome composition according to clause 1 or 2, wherein said isolated vegetable oleosomes are selected from the group consisting of isolated rapeseed oleosomes, isolated soybean oleosomes, isolated sunflower oleosomes, isolated linseed oleosomes, and a combination of two or more thereof. 4. The oleosome composition according to any one of the preceding clauses, wherein the one or more lipophilic dietary bioactive substance is selected from the group consisting of vitamin D, vitamin E, vitamin A, vitamin K, and ascorbyl palmitate, β-sitosterol, campesterol, stigmasterol, sitostanol campestanol, curcuminoids, carotenoids, and flavonoids, and combinations of two or more thereof. Docket No.: PT-1342-PCT 5. The oleosome composition according to any one of the preceding clauses, wherein the one or more lipophilic dietary bioactive substance is selected from the group consisting of vitamin D, vitamin E, vitamin A, vitamin K, and combinations of two or more thereof. 6. The oleosome composition according to any one of the preceding clauses, wherein the one lipophilic dietary bioactive substance is present or each of the more lipophilic dietary bioactive substances are present in the oleosome composition in an amount of from 0.1 to 1000 microgram, from 0.2 to 800 microgram, or from 0.3 to 600 microgram per gram, based on the total weight of lipids in the oleosome composition. 7. The oleosome composition according to any one of the preceding clauses, wherein the lipophilic dietary bioactive substance is vitamin D. 8. The oleosome composition according to any one of the preceding clauses, wherein the lipophilic dietary bioactive substance is vitamin A. 9. The oleosome composition according to any one of the preceding clauses, wherein the lipophilic dietary bioactive substance is vitamin E. 10. The oleosome composition according to any one of the preceding clauses, wherein the lipophilic dietary bioactive substance is vitamin K. 11. The oleosome composition according to any one of the preceding clauses comprising loaded isolated soybean oleosomes being isolated soybean oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance, which are present in the inside of said loaded isolated soybean oleosomes, and wherein at least 80 wt.% of the total weight of lipids of the composition is present in the oleosomes. 12. The oleosome composition according to any one of the preceding clauses comprising loaded isolated rapeseed oleosomes being isolated rapeseed oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance, which are present Docket No.: PT-1342-PCT in the inside of said loaded isolated rapeseed oleosomes, and wherein at least 80 wt.% of the total weight of lipids of the composition is present in the oleosomes. 13. The oleosome composition according to any one of the preceding clauses comprising loaded isolated linseed oleosomes being isolated linseed oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance, which are present in the inside of said loaded isolated linseed oleosomes, and wherein at least 80 wt.% of the total weight of lipids of the composition is present in the oleosomes. 14. The oleosome composition according to any one of the preceding clauses comprising loaded isolated sunflower oleosomes being isolated sunflower oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substance, which are present in the inside of said loaded isolated sunflower oleosomes, and wherein at least 80 wt.% of the total weight of lipids of the composition is present in the oleosomes. 15. The oleosome composition according to any one of the preceding clauses, wherein the oleosomes have an average globule diameter in a range of from 2.5 to 15 micron, preferably from 3.0 to 12 micron, more preferably from 4.0 to 10 micron. 16. The oleosome composition according to any one of the preceding clauses wherein the oleosome composition is further loaded with one or more sources of alpha-linolenic acid (ALA) and/or long-chain polyunsaturated fatty acids (LC-PUFA), which are present in the inside of said loaded isolated vegetable oleosomes. 17. The oleosome composition according to clause 16, wherein poly-unsaturated fatty acids (LC-PUFA) have a chain (“backbone”) comprising 20 or more carbon atoms and comprise more than one double bond in their backbone. 18. The oleosome composition according to clause 16 or 17 wherein LC-PUFA fatty acids are selected from the group consisting of arachidonic acid, docosahexaenoic acid, eicosapentaenoic acid, docosapentaenoic acid, or mixtures of two or more thereof. Docket No.: PT-1342-PCT 19. The oleosome composition according to any one of the preceding clauses wherein the oleosome composition is further loaded with one or more sources of medium-chain fatty acids (MCFA), which are present in the inside of said loaded isolated vegetable oleosomes. 20. The oleosome composition according to clause 19 wherein medium-chain fatty acids are selected from the group consisting of saturated fatty acids having a carbon chain length of 6, 8, 10, or 12 carbon atoms or mixtures of wo or more thereof. 21. The oleosome composition according to any one of the clauses 19 or 20 wherein medium- chain fatty acids MCFA are sourced from lipid sources selected from coconut oil, palm kernel oil, dairy lipids, fractions or mixtures thereof. 22. The oleosome composition according to any one of the preceding clauses wherein the oleosome composition is further loaded with 1,3-dioleoyl-2-palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), and 1-oleoyl-2-palmitoyl-3-linoleoyl glyceride (OPL) or mixture of two or more thereof, and which are present in the inside of said loaded isolated vegetable oleosomes. 23. The oleosome composition according to any of the preceding clauses, wherein the oleosome composition is containing from 0.2 to 10 wt.%, preferably from 1.2 to 8 wt.%, more preferably from 1.5 to 6 wt% of proteins based upon the dry weight of the composition. 24. An oleosome composition comprising loaded isolated vegetable oleosomes prepared by a) blending one or more sources of one or more sources of one or more lipophilic dietary bioactive substance and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances, which are present in the inside of said Docket No.: PT-1342-PCT loaded isolated vegetable oleosomes, and wherein at least 80 wt.% of the total weight of lipids in the composition is present in the oleosomes. 25. An oleosome composition comprising loaded isolated vegetable oleosomes prepared by a) blending one or more sources of one or more sources of one or more lipophilic dietary bioactive substance and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances, which are present in the inside of said loaded isolated vegetable oleosomes. 26. An oleosome composition comprising loaded isolated vegetable oleosomes prepared by a) blending one or more sources of one or more lipophilic dietary bioactive substance, ALA, LC-PUFA, MCFA’s 1,3-dioleoyl-2-palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), 1-oleoyl-2-palmitoyl-3-linoleoyl glyceride (OPL) or mixture of two or more thereof with isolated vegetable oleosomes, and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances, ALA, LC-PUFA, 1,3-dioleoyl-2- palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), 1- oleoyl-2-palmitoyl-3-linoleoyl glyceride (OPL) or mixture of two or more thereof and optionally other lipids, which are present in the inside of said loaded isolated vegetable oleosomes, and wherein at least 80 wt.% of the total weight of lipids in the composition is present in the oleosomes, and wherein the lipophilic dietary bioactive substances are selected from the group consisting of oil-soluble vitamins, phytosterols, curcuminoids, carotenoids, and flavonoids, and combinations of two or more thereof. 27. An oleosome composition comprising loaded isolated vegetable oleosomes prepared by Docket No.: PT-1342-PCT a) blending one or more sources of one or more lipophilic dietary bioactive substances, ALA, LC-PUFA, MCFA’s 1,3-dioleoyl-2-palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), 1-oleoyl-2-palmitoyl-3- linoleoyl glyceride (OPL) or mixture of two or more thereof with isolated vegetable oleosomes, and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances, ALA, LC-PUFA, 1,3-dioleoyl-2- palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), 1- oleoyl-2-palmitoyl-3-linoleoyl glyceride (OPL) or mixture of two or more thereof and optionally other lipids, which are present in the inside of said loaded isolated vegetable oleosomes, and wherein at least 80 wt.% of the total weight of lipids in the composition is present in the oleosomes, and wherein the lipophilic dietary bioactive substances are selected from the group consisting of vitamin D, vitamin E, vitamin A, vitamin K, and combinations of two or more thereof. 28. An oleosome composition comprising loaded isolated vegetable oleosomes prepared by a) blending one or more sources of one or more lipophilic dietary bioactive substances, ALA, LC-PUFA, MCFA’s 1,3-dioleoyl-2-palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), 1-oleoyl-2-palmitoyl-3- linoleoyl glyceride (OPL) or mixture of two or more thereof with isolated vegetable oleosomes, and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances, ALA, LC-PUFA, 1,3-dioleoyl-2- palmitoyl glyceride (OPO), 1,3-dilinoleoyl-2-palmitoyl glyceride (LPL), 1- oleoyl-2-palmitoyl-3-linoleoyl glyceride (OPL) or mixture of two or more thereof and optionally other lipids, which are present in the inside of said loaded isolated vegetable oleosomes, and wherein the lipophilic dietary bioactive substances are Docket No.: PT-1342-PCT selected from the group consisting of vitamin D, vitamin E, vitamin A, vitamin K, and combinations of two or more thereof. 29. A product comprising the oleosome composition according to any one of the preceding clauses, wherein said product is comprising at least one further ingredient different from oleosomes and the product is selected from the group consisting of food products, feed products, pharmaceutical products, personal care products, nutritional compositions and industrial products, and wherein the oleosome composition is present in a range of from 0.1 to 70.0 wt.% on dry matter of the product. 30. A product comprising the oleosome composition according to any one of clauses 1 to 28, wherein said product is comprising at least one further ingredient different from oleosomes and the product is selected from the group consisting of food products, pharmaceutical products, nutritional compositions, and wherein the oleosome composition is present in a range of from 0.1 to 70.0 wt.% on dry matter of the product. 31. The product according to clause 29 or 30, wherein the product is: ^ an infant formula, preferably growing-up milk ^ a drink for elderly people ^ a nutritional drink ^ a nutritional powder, preferably a sport nutrition powder ^ a powder for food fortification, ^ a nutrition bar or cookie, preferably a sports nutrition bar, or ^ a nutritional supplement. 32. The product according to clause 29 to 31, wherein the product is a nutritional composition comprising the oleosome composition and at least one additional nutritional ingredient, wherein the oleosome composition is present in a range of from 0.1 to 70.0 wt.%, preferably between 2.0 and 50.0 wt.% on dry matter of the nutritional composition, and Docket No.: PT-1342-PCT wherein the nutritional ingredient is preferably being selected from the group consisting of sources of proteins, sources of fats, sources of carbohydrates, sources of micronutrients, and a combination of two or more thereof. 33. The product according to clause 30 or 31, being an infant formula. 34. The product according to clause 33, said infant formula having a total content of lipids in a range of from 2.5 to 4.5 wt.% on the total weight of the infant formula, wherein at least 90% of the lipids of the infant formula is present in the oleosome composition; wherein the oleosome composition is comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more source of one or more lipophilic dietary bioactive substance; which are present in the inside of the loaded oleosomes and wherein the oleosome composition is comprising an amount of one or more lipophilic dietary bioactive substance in a range of from 0.1 to 400 microgram based on the total weight of lipids of the oleosome composition; and wherein at least 80 wt.% of the total weight of lipids in the oleosome composition is present in the oleosomes. 35. A process for preparing the oleosomes composition, wherein the process comprises the steps of: a) blending one or more sources of one or more lipophilic dietary bioactive substance and optionally additional lipids with isolated vegetable oleosomes in a ratio of the source of lipophilic dietary bioactive substances to oleosomes of from 1:99 to 95:5; and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances and optionally additional lipids, which are present in the inside of the loaded oleosomes and wherein at least 80 wt.% of the total weight of lipophilic dietary bioactive substances and at least 80 wt.% of the optionally added lipids in the composition is present in the oleosomes. Docket No.: PT-1342-PCT 36. A process for preparing the oleosomes composition, wherein the process comprises the steps of: a) blending one or more sources of one or more lipophilic dietary bioactive substance and optionally additional lipids with isolated vegetable oleosomes in a ratio of the source of lipophilic dietary bioactive substances to oleosomes of from 1:99 to 95:5; and b) subjecting the blend obtained from step a) to a high-shear force and obtaining an oleosome composition comprising loaded isolated vegetable oleosomes being isolated vegetable oleosomes loaded with one or more sources of one or more lipophilic dietary bioactive substances and optionally additional lipids, which are present in the inside of the loaded oleosomes. 37. The process according to clause 35 or 36, wherein the isolated oleosomes in step a) have a dry matter content in a range of from 30 to 80 wt.% on total weight of the oleosomes. 38. Use of the oleosome composition according to any one clauses 1 to 28 or prepared according to the process according to clause 32 or 33 as a carrier for one or more lipophilic dietary bioactive substance. 39. A process for preparing a product comprising the oleosome composition according to any one of the clauses 1 to 28, wherein the product is comprising at least one further ingredient different from oleosomes and the product is selected from the group consisting of food products, feed products, pharmaceutical products, personal care products, nutritional compositions, and industrial products, and the process comprises adding the oleosome composition according to any one of clauses 1 to 28, to at least one further ingredient different from oleosomes wherein the oleosome composition is added in an amount in a range of from 0.1 to 70.0 wt.% on dry matter of the product. 40. A process for preparing a product according to any one of the clauses 29 to 34, wherein the product is selected from the group consisting of food products, feed products, pharmaceutical products, personal care products, nutritional compositions, and industrial products and the process comprises adding the oleosome composition according to any Docket No.: PT-1342-PCT one of clauses 1 to 28, to at least one further ingredient different from oleosomes wherein the oleosome composition is added in an amount in a range of from 0.1 to 70.0 wt.% on dry matter of the product. EXAMPLES Analysis methods Protein measurement The protein content of the oleosomes was determined by the amount of nitrogen in the sample. This amount of nitrogen was analyzed using a combustion method. Combustion of the sample was performed at 1100°C. The amount of nitrogen was determined using a conductivity detector (LECO TruMAc). The protein content was calculated by multiplying the amount of nitrogen analyzed by 6.25. Measurement of fat content The amount of fat (lipids) in the isolated oleosomes was determined using the Soxhlet extraction method. It is expressed on total dry weight of the isolated oleosomes. Measurement of dry weight The percentage dry substance (%DS) of the isolated/loaded oleosomes was determined gravimetrically using an MA150 infrared balance (Sartorius). About 2 g of material (i.e. the wet weight (WW)) is applied on an aluminum dish with glass fiber pad. The moisture is evaporated at 105 °C until a stable weight is reached (i.e. the dry weight (DW)). The percentage dry substance is calculated according to the following formula: % _{^^ ^^ ൌ} ^{^^ ^^} ^ _{^ ^^ ^^ 100} Measurement of free oil in oleosome composition [0118] A pre-weighted sample of loaded isolated vegetable composition was mixed with heptane in a ratio of 1:5 sample:heptane and agitated for 15 minutes for extraction of the free oil into the heptane phase. After extraction the solution is centrifuged for 5 minutes Docket No.: PT-1342-PCT followed by filtration of the top layer through a 0.45µm filter. The free oil was quantified by GPC. Measurement of oil present in oleosomes of the oleosomes composition The amount of oil present in the loaded isolated oleosomes of the oleosome composition was calculated by subtracting the amount of free oil from the total oil content of the oleosome composition. Size measurement of isolated vegetable oleosomes and loaded isolated vegetable oleosomes [0119] To be able to measure the globule diameter of the oleosomes, a Mastersizer 3000 from Malvern equipped with a Hydro module was used during the measurements. A refractive index of 1.47, a dispersant refractive index of 1.33 and a particle absorption index of 0.01 is used to measure the oleosomes size. The concentration of the oleosomes in the buffer is such that an obscuration in the range from 8.0 to 8.5% in the Mastersizer equipment will be obtained. Obscuration within the Mastersizer is the amount of light blocked or scattered, by the particles. Therefore, the oleosomes are diluted in a buffer solution containing 10 mM sodium phosphate, pH 7.4, and 1.0 wt.% sodium dodecyl sulfate (SDS). For example, about 0.2 wt.% of oleosomes is diluted in the buffer solution and the dilution is further adjusted to obtain the obscuration. Once this optimal obscuration is obtained, the globule diameter is measured, and the average globule diameter (D50-value) can be calculated. Determination of oxidation stability The oxidation stability was determined by measuring the Oxidation Induction Period (OIP) by using an ML Oxipres device (Mikrolab). Samples were subjected to a high oxidative- stress environment in order to evaluate, in a short period of time, the resistance to oxidation. The oxygen uptake of the reactive components present in the samples was monitored as a pressure drop in function of time. An amount of sample (11-12 g) (i.e. isolated oleosomes or an oleosome composition) equivalent to 4 g of fat (lipids) was brought into a glass vessel which was placed in a pre-heated (70 °C) pressure vessel and filled with oxygen to 5 bar. Docket No.: PT-1342-PCT The OIP was determined as the intersection between the two tangents before and after the inflection point on the pressure graph. Determination of storage stability [0120] Storage stability was determined by visual observation of the loaded isolated vegetable oleosomes and synthetic emulsions. The phase separation (oil layer/water layer) was evaluated after 1 day and after 2 weeks storage time (samples were stored between 4- 10°C). Obtaining isolated high-oleic sunflower oleosomes [0121] In order to isolate oleosomes from high-oleic sunflowers, 100 g of dehulled seeds from high-oleic sunflower were soaked during 2 hours in deionized water in a ratio of seeds to water of 1:3 at a temperature of 20°C. The soaking water was discarded and the soaked seeds were washed with deionized water in a ratio of seeds to water of 1:2 at a temperature of 20°C. The washing water was discarded and the washed seeds were ground with deionized water in a ratio of seeds to water of 1:10 at a temperature of 20°C using a Thermomix® TM5 (Vorwerk) at a speed of 10700 rpm for 90 seconds. The obtained slurry was filtered over a Nylon filter with a pore diameter of 80 microns to obtain a filtrate, the retentate was discarded. The pH of the filtrate was adjusted to 7.5 with a sodium hydroxide solution and subsequently centrifuged for a first time using a Thermo Scientific Sorvall Legend at 4950g for 30 minutes, to yield a solid pellet (cell debris and insoluble proteins), a hydrophilic liquid supernatant phase (watery solution of proteins, carbohydrates and soluble fiber), and a hydrophobic creamy top layer with the desired oleosomes. The solid pellet and supernatant were discarded and the creamy top layer was diluted to 15% dry substance with deionized water, brought to pH 9.5 with a sodium hydroxide solution and centrifuged for a second time at 4950g for 30 minutes (Thermo Scientific Sorvall Legend), to yield a liquid supernatant phase and a creamy top layer with the desired isolated oleosomes, which were collected. The amount of proteins in the isolated oleosomes was 1.9 wt.% on basis of the dry weight of oleosomes. The amount of fat (lipids) in the isolated oleosomes was 35 wt.% on basis of the total weight of oleosomes, using the previous described method. The amount of fat (lipids) in the isolated oleosomes can be expressed on dry weight of oleosomes and was 97.2 wt.%. The difference up to 100% dry weight Docket No.: PT-1342-PCT represents traces of other components (not shown here). The composition is provided in Table 3. Obtaining isolated soybean oleosomes [0122] In order to isolate oleosomes from soybeans, soybeans were soaked during 24 hours in deionized water in a ratio of beans to water of 1:3 at a temperature of 4°C. The soaking water was discarded and the soaked beans were washed with deionized water in a ratio of beans to water of 1:2 at a temperature of 4°C. The washing water was discarded and the washed beans were ground with deionized water in a ratio of dry beans to water of 1:9 at a temperature of 4°C using a Thermomix® TM5 (Vorwerk) at a speed of 10700 rpm for 90 seconds. The obtained slurry was filtered over a Nylon filter with a pore diameter of 80 microns to obtain a filtrate, the retentate was discarded. The pH of the filtrate was adjusted to 11 with a sodium hydroxide solution and subsequently centrifuged at 50 °C using a Thermo Scientific Sorvall Legend at 4950g for 60 minutes, to yield a solid pellet (cell debris and insoluble proteins), a hydrophilic liquid supernatant phase (watery solution of proteins, carbohydrates and soluble fiber), and a hydrophobic creamy top layer with the desired oleosomes. The solid pellet and supernatant were discarded after collecting the cream layer. The amount of proteins in the isolated oleosomes was 8.3 wt.% on basis of the dry weight of oleosomes. The amount of fat (lipids) in the isolated oleosomes was 38 wt.% on basis of the total weight of oleosomes, using the previous described method. The amount of fat (lipids) in the isolated oleosomes can be expressed on dry weight of oleosomes and was 90.5 wt.%. The composition is provided in Table 3. Loading of the isolated oleosomes Step a) blending one or more sources of one or more lipophilic dietary bioactive substance with isolated oleosomes [0123] The isolated oleosomes were blended with one or more sources of one or more lipophilic dietary bioactive substance (see recipes below). In order to obtain an oleosome composition comprising loaded isolated vegetable oleosomes having a targeted fatty acid profile, isolated vegetable oleosomes were further blended in Docket No.: PT-1342-PCT step a) with additional oils as one or more sources of specific fatty acids. The targeted fatty acid profile was that of the nutritional drink or the young child formula wherein the oleosome composition was used as a source of substantially all fats. [0124] The isolated oleosomes were blended with a blend of liquid oils, HO sunflower oil as a source of oleic acid, flaxseed oil as a source of ALA, Schizochytrium spec. oil as a source of DHA (= LC-PUFA), and MCT (medium chain triglyceride) oil as a source of MCFA. The isolated oleosomes were blended according to the recipes in Table 1: Example 1 using high-oleic sunflower oleosomes and Example 2 using soybean oleosomes. The ratio of the amount of isolated oleosomes to the amount of sources of MCFA and/or LC-PUFA and optionally additional lipids is between 50:50 and 60:40. The liquid oils (according to Table 1) were added to the isolated oleosomes by gentle mixing using a spatula, until the oil is finely dispersed. [0125] For the formulation of the loading recipes, only the lipid phase contribution from the oleosomes was considered (disregarding the water and protein content) in order to reach the desired fatty acids profile for the application examples. The actual total amount of added isolated oleosomes can be calculated from the overall composition as provided in Tables 3 or 4. Table 1. Recipes for blending of isolated oleosomes with one or more sources of one or more lipophilic dietary bioactive substance Lipid phase Example Exampl Example Example 1 e 2 3 4 Docket No.: PT-1342-PCT % * [0126] The fatty acid profile of the different oils used for the loading (as well as high- oleic sunflower oil and soybean oil) are shown in Table 2 for all fatty acids that are present in 1 % or more; the numbers hence do not add up to 100%. Where totals are given, the fatty acids that are present in less than 1 % are also included even if not specifically mentioned in the table below; the numbers therefore do not always add up to the total number. [0127] The fatty acid profile of the isolated and the loaded isolated oleosomes, according to Examples 1 and 2 is specified in Table 3. Table 2. Fatty acid profile of oils used for blending with the isolated oleosomes Docket No.: PT-1342-PCT C 0 0 0 ressed ** fatty acid profile based on Osmond et al., Animals 2021, 11, 1185 *** fatty acid profile based on MCT oil commercially available Docket No.: PT-1342-PCT Step b) subjecting the blend obtained from step a) to a high-shear force [0128] The blends of isolated oleosomes and liquid oils as obtained from step a), as described in Table 1, are subjected to a high shear mixing using an IKA Ultra Turrax T25 Digital with a disperser S25N-8G. High shear mixing was applied for 3 minutes at a speed of 21500 rpm (which corresponds to a tip velocity of 6.7 m/s). [0129] Table 3 specifies the oleosome composition comprising the isolated high-oleic (HO) sunflower oleosomes, isolated soybean oleosomes as well as the loaded isolated oleosomes according to Examples 1 and 2. Table 3. Composition of isolated high-oleic (HO) sunflower oleosomes, soybean oleosomes and the oleosome compositions comprising the loaded isolated oleosomes. Isolated HO Isolated Oleosome composition nfl r S b n 2 Docket No.: PT-1342-PCT [0130] # The amount of fatty acids that is expressed in table 3 as wt.% of the fatty acid profile of the oleosome composition can also be expressed based on dry weight of the oleosome composition. For example, a loaded oleosome composition having C18.1 content of 49.0 wt.% based on the fatty acid profile of the oleosome composition, and the oleosome composition having a lipid content of 98.5 wt.% expressed on dry weight of the oleosome composition, has C18.1 content expressed on dry weight of the oleosome composition of 49.0 x 0.983 = 45.8 wt.%. Oxidative and storage stability of the oleosome composition [0131] The oxidative and storage stability of the oleosome composition of Example 3 and Example 4 was compared to the stability of a corresponding synthetic emulsions (Comparative example 3 and Comparative example 4). The results are shown in Table 4. The isolated HO sunflower oleosomes used for example 3 and 4, is the hydrophobic creamy top layer obtained before dilution (is non-washed oleosomes). The isolated HO sunflower oleosomes were further blended with 20 wt. % Schizochytrium Oil-2 and 20 wt. % MCT oil- 2. The blend was subject to a high-shear force (high shear mixing IKA Ultra Turrax T25 Digital with a disperser S25N-8G), for 3 minutes at a speed of 21500 rpm. The synthetic emulsion was obtained by blending 31 wt. % HOSFO, 2 wt. % sunflower lecithin, 2.5 wt. % pea protein and 64.5 wt. % water. The blend was high sheared at 2000 rpm for 3 mins (IKA® EUROSTAR 40 digital). The synthetic emulsion was further blended with 20 wt% Schizochytrium Oil-2 and 20 wt% MCT oil-2. The same high shear conditions were applied as those used for the loading of the isolated HO sunflower oleosomes. Docket No.: PT-1342-PCT Table 4. The oxidative and storage stability of the oleosome composition of Example 3 and 4 and corresponding synthetic emulsions (Comparative example 3 and 4) Isolated Oleosome Oleosome S nthetic S nthetic e Docket No.: PT-1342-PCT ¤ = Loading efficiency was calculated (total lipids - free lipids) / total lipids*100% [0132] The synthetic emulsions showed higher free lipid content, poorer emulsification capacity (although lecithin was present) and more lipid phase separation after storage, compared to loaded isolated HO sunflower oleosomes, which showed less free lipid, better loading efficiency and were more stable after storage (visual observation). The oleosomes loaded with tocopherols showed improved oxidative stability and better protective effect of the bioactive compound than the synthetic emulsion. Nutritional compositions according to the present invention The following food product and nutritional composition according to the present invention have been prepared using the oleosome compositions from Examples 1 and 2 (See table 5). ^ Recipe A: Food product, being a supplement for muscle health and immune boost ^ Recipe B: Nutritional composition, being a young child formula (Growing-up milk) Table 5. recipe using Example 1 and 2 Recipe A Recipe B e Supplement for muscle health and immune boost [0133] The food product according to recipe A is a supplement for muscle health and immune boost. It is “pure” oleosome composition and is hence a use of the oleosome composition according to the present invention as a supplement. Recipe B doesn’t contain any additional (nutritional) components in addition to the oleosome composition. It is a Docket No.: PT-1342-PCT highly concentrated emulsion that may be mixed into food and drink, or that may be taken by spoon. Young child formula (Growing-up milk) [0134] A young child formula (growing-up milk) was prepared according to recipe B. For the preparation, a stirring tank is filled with water at 20°C to which skimmed milk powder, demineralized whey protein, and lactose were added and stirred to disperse for a period of time sufficient to hydrate. Afterwards, the minerals and vitamins are added and dispersed. Subsequently, the oleosome composition was added slowly while stirring to disperse well. The pH is adjusted to 6.7- 7.0 if needed using disodium hydrogen phosphate or dipotassium hydrogen phosphate. The product obtained from recipe B was subsequently pasteurized at a temperature of 85°C for 30 seconds before storing for later use. The composition of the young child formula is shown in table 6. Table 6. Composition of the nutritional supplement and the young child formula Young child formula Docket No.: PT-1342-PCT [0135] Although certain aspects of the invention have been described, the scope of the appended claims is not intended to be limited solely to these specific aspects. The claims are to be construed literally, purposively, and/or to encompass equivalents. The scope of the present invention is defined by the appended claims. One or more of the objects of the invention are achieved by the appended claims.